United States · Venture startup

Who invested in Innova Vascular

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$10Mraised across 1 round since 2025, from 1 source

Latest round
Venture, $10MJun 2025
Investors
1
See who backed them

The rounds

  1. Jun 2025
    Venture$10M

    Source recordedSEC filing: $2.2M sold, first sale Jun 2021

Founders and team

From Innova Vascular's own website: 3 on the team.

  • Dr. Sanjay ShrivastavaChief Executive Officer
  • Dr. Owen O'NiellOrthopedic Surgeon & President
  • Federico AloisiInvestment Director

Everyone who backed them

MedTech InnovatorAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Innova Vascular as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

SeedFolioVC firmPer its own site

Quick answers about Innova Vascular

Who invested in Innova Vascular?

Innova Vascular's investors include MedTech Innovator.

How much has Innova Vascular raised?

Innova Vascular has raised $10M across 1 round since 2025.

When did Innova Vascular last raise?

Innova Vascular's most recent round was a Venture of $10M in Jun 2025.

What was Innova Vascular's biggest round?

Its most recent round, $10M in Jun 2025, is also its largest on record.

Who backed Innova Vascular first?

Innova Vascular's first round on record, in Jun 2025, was backed by MedTech Innovator.

What stage is Innova Vascular at?

Innova Vascular's latest named round is a Venture, in Jun 2025.

Where is Innova Vascular based?

Innova Vascular is based in the United States.

Companies like Innova Vascular

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.